MTOR and acute myeloid leukemia: In this study, inhibition of glutamine flux in AML cells using the competitive ASCT2 inhibitor 2-amino-4-bis(aryloxy benzyl)amino butanoic acid (V-9302) led to a reduction in glutamine and leucine uptake and the inhibition of mTOR, ultimately resulting in cell death.